AwardedArchived
6505--Rituximab Effective 09/15/2025 - 09/14/2026
Awarded tounder 36E79725D0032 (source: SAM.gov award notice)• $74.0M
Overview
- Posted
- April 29, 2025
- Notice type
- Award Notice
Notice details
- Last updated
- Nov 15, 2026
- First published
- Last updated on SAM.gov
- Award date
- Apr 29, 2025
- Award amount (SAM.gov award notice)
- $74.0M
Identifiers
- Solicitation number
- 36E79725R0021
- Notice ID
- bf70e13c1f034cf3af08f4cc0609fd75
- Award number (PIID)
- 36E79725D0032
Description
Rituximab
Award Overview
Award Number
36E79725D0032
Award Amount (SAM.gov award notice)
$74.0M
Award Date
Apr 29, 2025
Awardee
Awardee UEI
MHBQULRMEEJ5
Line Item Number
2
Original Solicitation
Notice ID: bf70e13c1f034cf3af08f4cc0609fd75
Posted Date: Apr 29, 2025
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 9, 2026
- —Signed Nov 5, 2026
- —Signed Nov 5, 2026
- —Signed Nov 3, 2026
- —Signed Sep 23, 2026
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
36E79725D0032_1.docx
22 KBAdded in Award Notice version 3Posted
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
6505--Rituximab Effective 09/15/2025 - 09/14/2026
Other notices for this solicitation
- Pre-SolicitationRelated noticeJan 28, 2025
6505--Rituximab and Biosimilars
- SolicitationRelated noticeFeb 10, 2025
6505--Rituximab and Biosimilars
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79725R0021
Archive Date
Jun 28, 2025